Up a level |
(2023) Intravesical Gemcitabine versus Intravesical Bacillus Calmette-Guerin for the Treatment of Intermediate-Risk Non-Muscle Invasive Bladder Cancer: A Randomized Controlled Trial. Urology Journal. pp. 123-128. ISSN 1735-546X (Electronic) 1735-1308 (Linking)